PH vs TRDA · P/E 28, rev $19.85B vs P/E 12, rev $210.8M
Parker-Hannifin Corporation (PH) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
PH currently screens at market cap $91.89B and trailing P/E 27.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the PH and TRDA stock pages for the full models.
Not investment advice.